Lithuania - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Lithuania Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases decreased by 2.5% year on year. In 2019, the country was ranked number 97 among other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases at 246 Cases. Lithuania is overtaken by Ecuador, which was ranked number 96 with 255 Cases and is followed by Mongolia with 240 Cases. India topped the ranking with 66,255 Cases in 2019, a growth of 13.6% versus 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo recorded the best 5 years average growth at +171.1% per year, while Croatia witnessed the worst performance at -100% per year.
Loading...
| Date | Units (Cases) |
|---|---|
| 2019 | 246.00 |
| 2018 | 252.00 |
| 2017 | 264.00 |
| 2016 | 255.00 |
| 2015 | 248.00 |
How does Lithuania rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
| # | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
| 3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
| 95 |
#95
Turkey
|
256 | 2019 | -0.4 % | -6.0 % | View data | |
| 97 |
#97
Lithuania
|
246 | 2019 | -2.4 % | -2.5 % | View data | |
| 98 |
#98
Mongolia
|
240 | 2019 | +2.6 % | -5.5 % | View data | |